Information Provided By:
Fly News Breaks for March 5, 2018
EOLS
Mar 5, 2018 | 06:54 EDT
Mizuho analyst Irina Koffler initiated Evolus with a Buy and $21 price target. Koffler expects Evolus and its low-cost toxin to create a niche in the attractive cash-pay cosmetic market.
News For EOLS From the Last 2 Days
There are no results for your query EOLS